Qiuhong Li - Publications

Rituximab is associated with accelerated dialysis independence in anti-glomerular basement membrane disease: a retrospective cohort analysis of renal survival.

Journal: Frontiers in immunology

Published: March 21, 2026

Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates diabetic nephropathy via suppressing SLC7A11-mediated ferroptosis.

Journal: International immunopharmacology

Published: December 11, 2025

Efficacy and safety of Nefecon in IgA nephropathy: real world clinical practice.

Journal: Frontiers in immunology

Published: December 06, 2025

CircTHBS1 aggravates peritoneal fibrosis by sponging miR-18a-5p and interacting with CTGF.

Journal: The international journal of biochemistry & cell biology

Published: October 28, 2025

Association between the oxidative balance score and diabetic kidney disease in diabetes mellitus patients: insights from NHANES 2011-2018.

Journal: Frontiers in nutrition

Published: September 11, 2025

Efficacy and safety of finerenone with SGLT2i in IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 18, 2025

Renal fat fraction quantified by MRI-Dixon predicts the renal function progression in patients with type 2 diabetes mellitus: a prospective cohort study.

Journal: Journal of endocrinological investigation

Published: August 04, 2025

Effect and Safety of Finerenone in Patients with IgA Nephropathy.

Journal: Journal of inflammation research

Published: May 05, 2025

Nomogram for thromboembolic events in primary membranous nephropathy associated with PLA2R antibody.

Journal: Scientific reports

Published: September 16, 2024